AGP Picks
View all

My Healthcare Reporter
Provided by AGP

My Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Healthcare Reporter.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 6, 2026

Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update
Aug. 6, 2026

Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update

Indeterminate GlobeNewswire
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Aug. 6, 2026

Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
MBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights
Aug. 6, 2026

MBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights

Indeterminate GlobeNewswire
Proscia Receives New FDA 510(k) Clearance for Concentriq AP-Dx with Predetermined Change Control Plan
Aug. 6, 2026

Proscia Receives New FDA 510(k) Clearance for Concentriq AP-Dx with Predetermined Change Control Plan

Indeterminate GlobeNewswire
PwC and Zyter Collaborate to Help Healthcare Organizations Transform Total Cost of Care and Improve Measurable Outcomes
Aug. 6, 2026

PwC and Zyter Collaborate to Help Healthcare Organizations Transform Total Cost of Care and Improve Measurable Outcomes

Indeterminate GlobeNewswire
Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week
Aug. 6, 2026

Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week

Indeterminate GlobeNewswire
Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
Aug. 6, 2026

Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Indeterminate GlobeNewswire
Nano-X Imaging Ltd. Announces Pricing of a $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Aug. 6, 2026

Nano-X Imaging Ltd. Announces Pricing of a $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire
Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement
Aug. 6, 2026

Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement

Indeterminate GlobeNewswire
Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results
Aug. 6, 2026

Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Ascendis Announces COACH Week 78 Results and Provides Update on Achondroplasia Programs and YUVIWEL® Uptake in the U.S.
Aug. 6, 2026

Ascendis Announces COACH Week 78 Results and Provides Update on Achondroplasia Programs and YUVIWEL® Uptake in the U.S.

Indeterminate GlobeNewswire
Clearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study
Aug. 6, 2026

Clearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study

Indeterminate GlobeNewswire
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
Aug. 6, 2026

argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.

Indeterminate GlobeNewswire
SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights
Aug. 6, 2026

SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights

Indeterminate GlobeNewswire
Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress
Aug. 6, 2026

Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress

Indeterminate GlobeNewswire
Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
Aug. 6, 2026

Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026

Indeterminate GlobeNewswire
Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update
Aug. 6, 2026

Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease
Aug. 6, 2026

BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease

Indeterminate GlobeNewswire
Cronos Group Reports 2026 Second Quarter Results
Aug. 6, 2026

Cronos Group Reports 2026 Second Quarter Results

Indeterminate GlobeNewswire
Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates 
Aug. 6, 2026

Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates 

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

My Healthcare Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.